| Gene symbol | KLRK1 | Synonyms | CD314, D12S2489E, KLR, NKG2-D, NKG2D | Type of gene | protein-coding |
| Chromosome | 12 | Map location | 12p13.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | killer cell lectin like receptor K1 | ||||
| GTO ID | GTC2939 |
| Trial ID | NCT05247957 |
| Disease | Multiple Myeloma |
| Altered gene | NKG2D |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | NKG2D CAR-NK cells |
| Recruitment status | Terminated |
| Title | NKG2D CAR-NK Cell Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia |
| Year | 2021 |
| Country | China |
| Company sponsor | Hangzhou Cheetah Cell Therapeutics Co., Ltd |
| Other ID(s) | CARNK-001 |
| Cohort 1 | |||||||||||
|
|||||||||||